Cover Image
市場調查報告書

CZ BioMed Corp的產品平台分析

CZ BioMed Corp - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 256005
出版日期 內容資訊 英文 26 Pages
訂單完成後即時交付
價格
Back to Top
CZ BioMed Corp的產品平台分析 CZ BioMed Corp - Product Pipeline Review - 2015
出版日期: 2015年12月23日 內容資訊: 英文 26 Pages
簡介

CZ BioMed Corp是總公司設立於美國的生物科技企業。正在進行操作遺傳基因用以消滅癌細胞的感冒病毒(RVLYSIS)之藥物研發·開發,商品化。RVLYSIS具有可消滅癌細胞,引發癌細胞細胞凋亡的功能。

本報告提供CZ BioMed Corp 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,加上最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

CZ BioMed Corp 基本資料

  • CZ BioMed Corp 概要
  • 主要資訊
  • 企業資料

CZ BioMed Corp :R&D概要

  • 主要的治療範圍

CZ BioMed Corp :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

CZ BioMed Corp :開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

CZ BioMed Corp :藥物簡介

  • Brvlysis
  • Cervlysis
  • Corvlysis
  • Hervlysis
  • Lurvlysis
  • Mervlysis
  • Ovarvlysis
  • Panrvlysis
  • Prorvlysis

CZ BioMed Corp :開發平台分析

  • 各給藥途徑
  • 各分子類型

CZ BioMed Corp :最新的開發平台情形

CZ BioMed Corp :總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07922CDB

Summary

Global Markets Direct's, 'CZ BioMed Corp - Product Pipeline Review - 2015', provides an overview of the CZ BioMed Corp's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of CZ BioMed Corp's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of CZ BioMed Corp including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of CZ BioMed Corp's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the CZ BioMed Corp's pipeline products

Reasons to buy

  • Evaluate CZ BioMed Corp's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of CZ BioMed Corp in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the CZ BioMed Corp's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of CZ BioMed Corp and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of CZ BioMed Corp
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of CZ BioMed Corp and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • CZ BioMed Corp Snapshot
    • CZ BioMed Corp Overview
    • Key Information
    • Key Facts
  • CZ BioMed Corp - Research and Development Overview
    • Key Therapeutic Areas
  • CZ BioMed Corp - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • CZ BioMed Corp - Pipeline Products Glance
    • CZ BioMed Corp - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • CZ BioMed Corp - Drug Profiles
    • Brvlysis
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Cervlysis
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Corvlysis
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Hervlysis
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Lurvlysis
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Mervlysis
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Ovarvlysis
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Prorvlysis
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • CZ BioMed Corp - Pipeline Analysis
    • CZ BioMed Corp - Pipeline Products by Route of Administration
    • CZ BioMed Corp - Pipeline Products by Molecule Type
  • CZ BioMed Corp - Recent Pipeline Updates
  • CZ BioMed Corp - Dormant Projects
  • CZ BioMed Corp - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • CZ BioMed Corp, Key Information
  • CZ BioMed Corp, Key Facts
  • CZ BioMed Corp - Pipeline by Indication, 2015
  • CZ BioMed Corp - Pipeline by Stage of Development, 2015
  • CZ BioMed Corp - Monotherapy Products in Pipeline, 2015
  • CZ BioMed Corp - Preclinical, 2015
  • CZ BioMed Corp - Pipeline by Route of Administration, 2015
  • CZ BioMed Corp - Pipeline by Molecule Type, 2015
  • CZ BioMed Corp - Recent Pipeline Updates, 2015
  • CZ BioMed Corp - Dormant Developmental Projects,2015

List of Figures

  • CZ BioMed Corp - Pipeline by Top 10 Indication, 2015
Back to Top